| abstract |
The use of a compound to treat triple negative breast cancer. A compound represented by formula (I) or a pharmaceutically acceptable salt thereof. Particularly preferred is enzalutamide. (X is trifluoromethyl, etc .; W is O, etc .; R1 and R2 together are alkyls, substituted alkyls containing less than 8 carbon atoms, including haloalkyl, etc .; R3 is H, halogen, methyl, C1-C4 alkoxy, formyl, haloacetoxy, trifluoromethyl, etc .; R4 is H, halogen, alkyl or haloalkyl) [Selection figure] None |